Global Infectious Diseases Molecular Diagnostics Market Growth (Status and Outlook) 2025-2031

The global Infectious Diseases Molecular Diagnostics market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.

The Infectious Diseases Molecular Diagnostics market is driven by the need for rapid and accurate diagnostics for infectious diseases and the increasing global incidence of such diseases. Molecular diagnostics offer advanced methods for detecting infectious pathogens and monitoring their genetic variations. The rise in emerging infectious diseases and the demand for point-of-care testing contribute to market growth as healthcare systems seek reliable tools for early detection and effective disease management. Moreover, advancements in diagnostic technologies, including nucleic acid amplification techniques and multiplex assays, align with improved sensitivity and specificity of infectious disease diagnosis. However, the market also faces challenges, including establishing standardized testing protocols and addressing cost barriers for widespread adoption. Additionally, ensuring accessibility and navigating regulatory approvals for new diagnostics can pose obstacles for manufacturers. To succeed, stakeholders must focus on developing innovative molecular diagnostic solutions, collaborating with public health agencies, and addressing the challenges to meet the increasing demand for rapid and accurate detection of infectious diseases.

LPI (LP Information)' newest research report, the “Infectious Diseases Molecular Diagnostics Industry Forecast” looks at past sales and reviews total world Infectious Diseases Molecular Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Infectious Diseases Molecular Diagnostics sales for 2025 through 2031. With Infectious Diseases Molecular Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Diseases Molecular Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Infectious Diseases Molecular Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Infectious Diseases Molecular Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infectious Diseases Molecular Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Diseases Molecular Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Diseases Molecular Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Diseases Molecular Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others

Segmentation by Application:
Hospital
Third-party Testing Agency
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Qiagen
Illumina
Abbott
Hologic
BioMerieux
Danaher (Cepheid)
Myriad Genetics
DAAN Gene
Agilent
Genomic Health
BD
Foundation Medicine

Please note: The report will take approximately 2 business days to prepare and deliver.